VRAYQ vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, AONCW, AONC, APLMW, and ARTLW
Should you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), American Oncology Network (AONC), Apollomics (APLMW), and Artelo Biosciences (ARTLW). These companies are all part of the "medical" sector.
ViewRay (NASDAQ:VRAYQ) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, valuation and dividends.
ViewRay and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
180 Life Sciences has lower revenue, but higher earnings than ViewRay.
15.5% of ViewRay shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, 180 Life Sciences had 2 more articles in the media than ViewRay. MarketBeat recorded 2 mentions for 180 Life Sciences and 0 mentions for ViewRay. 180 Life Sciences' average media sentiment score of 1.25 beat ViewRay's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.
Summary
ViewRay beats 180 Life Sciences on 3 of the 5 factors compared between the two stocks.
Get ViewRay News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VRAYQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
VRAYQ vs. The Competition
Related Companies and Tools
